COVID-19 Impact on Hematological and Biochemical Parameters on Outcomes of Admitted Patients.

COVID-19 an ongoing pandemic with high transmission and mortality rate gets the researchers' attention to the disease. The disease burden on the health care system focuses on the COVID-19 impacts on the hematological and biochemical parameters. This study aimed to focus on the laboratory indicators that fluctuate in COVID-19. The single-center cross-sectional study in the pathology department of POF hospital Wah Cantt from August 2021 to December 2021. Three hundred positive COVID-19 patients were included in the study. The138 (46%) were males and 162 (54%) females and the mean age was 58 ± 15.06 (range 5 – 86). The biochemical indicator raised in COVID-19 included CPK (191.25 ± 507.39), CRP (68.81 ± 70.95), LDH (429.48 ± 246.96), and ALT (46.50 ± 43.23). In hematological parameters, only neutrophils elevated (70.00 ± 13.52) lymphocytes decreased. Laboratory parameters measured were similar values in recovered and death cases. The findings suggest the raised level of CRP, LDH, CPK, ALT, ferritin, D-Dimer, and neutrophils predict the early diagnosis and prompt treatment.